Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.
Bloomberg Talks
2,468 clip(s)
Chief Economist at Wolfe Research Stephanie Roth Talks November US CPI Report
Dan Ives, Wedbush Securities, Talks Trump Trump Media & TAE Technologies Merger
Kathy Wylde Talks Role in Mamdani Transition Team